Through a network pharmacology analysis, the anti-obesity effect of hispidulin was predicted to act on estrogen, prolactin, Rap1, and PI3K-Akt signaling pathways by targeting AKT1, SRC, EGFR, and GSK3B. This evidence concerns the gene GSK3B and obesity due to melanocortin 4 receptor deficiency.